LeonaBio ($LONA) Shares Plunge -55% on Warrant Exercise Overhang (See the latest news for any ticker on Tickeron.) LeonaBio (LONA) shares fell roughly 55% over the past 30 days, from about $7.83 to approximately $3.52, as a warrant-exercise overhang triggered heavy selling. The sharpest decline followed the company's September 25 announcement opening an exercise window for Series A warrants covering about 23 million shares at $6.35 per share. The dilution risk outweighed otherwise steady clinical progress on the Phase 3 ELAINE-3 trial of lasofoxifene in ESR1-mutated metastatic breast cancer. $CANF $ICU $GNPX $MLEC
published
LeonaBio ($LONA) Shares Plunge -55% on Warrant Exercise Overhang (See the latest news for any ticker on Tickeron.) LeonaBio (LONA) shares fell roughly 55% over the past 30 days, from about $7.83 to approximately $3.52, as a warrant-exercise overhang triggered
$LONA$CANF$ICU$GNPX$MLEC
Latest documented BWB result
BWB member result
Exit /ES with a 14 Pt (56 tick) profit
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.
